| Industry Analysis |
| Misjudging Leadership In the BioPharma Industry |
 | By Louis Garguilo, Executive Editor, Outsourced Pharma
We can learn about leadership from Lego. Or rather, this plastic building-block company can show us how little we actually understand the subject. We'll begin with toys but proceed quickly and seriously to how we may be misjudging "leadership" in the biotech and pharmaceutical (BioPharma) industry. |
| FROM THE EDITOR: 21st Century Cures Gets Closer To Revolutionizing The Pharma Industry |
 | By Ed Miseta, Chief Editor, Outsourced Pharma
If you’re a regular reader of my articles, you know my background is in economics, and I tend to favor free markets over more central control. But when I first became aware of the 21st Century Cures initiative last year, I felt it was something the industry needed. |
|
| » Discovery Research/Preclinical Development |
| ARTICLE: Partnership Prepares Next Generation Of Animal Technicians |
By April George, DVM
The value of animal research to advancing new medicines can't be understated. Making sure the highest possible standards of animal welfare are upheld is a key element of that value — now and in the future. |
| ARTICLE: Getting The Most Out Of Your Viral Clearance Study |
 | By John Zehmer, Ph.D., Senior Scientist and Study Director, BioReliance
Conducting a viral clearance study is an important step on the road toward getting your biomolecule into the clinic and on its way to becoming a drug. However, since most companies do not have the systems in place to support a regulated virological study of this kind, this will likely mean engaging a contract research organization as a partner. |
|
|
| » Drug Development |
| WHITE PAPER: Building An Analytics-Driven Corporate Culture |
By Comprehend Systems
Analytics — identifying meaningful patterns in data to gain valuable insights — has become a core focus of the life sciences industry today, as it has in many other sectors, driving clinical and operational improvements. |
|
|
| » Drug Substance/Drug Product Manufacturing |
| FROM THE EDITOR: WuXi Historic Company In Pharma Outsourcing |
By Louis Garguilo, Executive Editor, Outsourced Pharma
Hard to argue with the categorical proposition that no single entity has fundamentally influenced the growth and shape of global pharma outsourcing as has WuXi of Shanghai. What has been debated is the nature of that impact on the industry. I sat down with Todd D. Nelson, Ph.D., VP of operations, alliance management and business development, WuXi STA, to discuss. |
| FROM THE EDITOR: ISPE Releases Drug Shortages Prevention Plan At Annual Meeting |
By Ed Miseta, Chief Editor, Outsourced Pharma
ISPE has released its Drug Shortages Prevention Plan at a media conference held during its annual meeting at Caesars Palace in Las Vegas. Present at the conference were new president and CEO John Bournas, strategic advisor John Berridge, and Drug Shortage Prevention Plan leaders Joe Famulare, Paul D'Eramo, Donna Gulbinski, and Sam Venugopal. |
|
|
| » Packaging/Assembly/Logistics |
| WHITE PAPER: Using Dry Ice When Shipping Air Freight |
By Mark Mohr, CSafe Global
Healthcare product manufacturers, transportation providers, and distributors have a moral, and in most cases, a regulatory responsibility to help ensure the product arrives to the end user intact. Protection of product efficacy demands use of the latest reliable technologies available. People's lives truly depend on it. |
|
|
|
|
|
|
|
|
|
댓글 없음:
댓글 쓰기